Downstream Processing

Waters launches LC platform-neutral bioseparations system

06-Feb-2018 By Staff Reporter

Waters Corporation says its latest bioseparations system can drive cost-savings through reduced solvent volumes and decreased run times.

Celltrion slammed with US FDA warning at biosimilar site

02-Feb-2018 By Dan Stanton

Celltrion says supply of Pfizer’s Inflectra is secure, despite receiving a US FDA warning letter at its biosimilar production plant in Korea.

Pall the ‘stand-out’ in Danaher’s life sciences Q4 results

31-Jan-2018 By Staff Reporter

Pall Corporation reported its best quarterly growth since its acquisition by Danaher in 2015.

Sanofi expanding Fabrazyme plant in MA

31-Jan-2018 By Dan Stanton

Sanofi will expand its Framingham, Massachusetts biomanufacturing facility by 14,820 square-foot to support its product portfolio.

Paragon expansion to address ‘deficit in gene therapy CDMO capacity’

24-Jan-2018 By Dan Stanton

The CDMO says it is building a 150,000 square-foot biomanufacturing facility in Maryland in preparation for a double-digit growth in the gene therapy space.

Cellular Biomedicine Group adopts GE Healthcare tech for CAR-T therapy production

19-Jan-2018 By Gareth Macdonald

Cellular Biomedicine Group Inc (CBMG) has selected GE Healthcare’s FlexFactory technology for its CAR-T therapy production facility in Shanghai, China.

Meissner expands aseptic fill/finish range through PDC acquisition

18-Jan-2018 By Staff Reporter

Meissner Filtration Products has bolstered its automated filling offerings through the acquisition of PDC Aseptic Filling Systems.

Aviragen Vaxart merger to create $264m tablet vaccine firm

15-Jan-2018 By Dan Stanton

Aviragen Therapeutics has called on shareholders to back its proposed merger with oral vaccine delivery firm Vaxart.

Sartorius inks deal for Quad's T cell activation tech

12-Jan-2018 By Dan Stanton

Quad Technologies has teamed with Sartorius Stedim Biotech to expand the reach of its T-cell activation reagent for cell and gene therapy production.

VC banks on CAR T through acoustic wave separation firm investment

12-Jan-2018 By Dan Stanton

Venture capital company Dynamk Capital has invested in FloDesign Sonics citing its acoustic wave separation technology’s application in the growing CAR T cell sector.

Shire seeks US FDA OK to make first med at Covington

02-Jan-2018 By Gareth Macdonald

Shire plc has asked the US FDA for permission to make its first product at its facility in Covington, Georgia.

3M aims at double-digit growth in $5.5bn biopharma filtration market

20-Dec-2017 By Dan Stanton

The full integration of filtration tech company Membrana is driving double-digit growth rate for 3M’s biopharma purification business, the firm says.

TxCell set to transfer production process for candidate organ rejection cell therapy to CMO

19-Dec-2017 By Gareth Macdonald

TxCell SA has developed the production process for it range of CAR-Treg based therapies and is preparing to transfer it to its CMO ahead of first-in-human trials.

PBI buys BaroFold to expand biomanufacturing offering

19-Dec-2017 By Gareth Macdonald

Pressure Biosciences Inc. (PBI) has acquired BaroFold Inc. adding protein folding technology and expanding its research services offering.

Lilly to pump $1.2bn into its biomanufacturing in 2018

15-Dec-2017 By Dan Stanton

Eli Lilly has projected an increased spend across its biomanufacturing network next year to support bulk production and fill/finish of monoclonal antibodies.